600223.SH
Lushang Freda Pharmaceutical Co., Ltd.
SSE · Healthcare · Real Estate - Development · CN
CNY 5.55
+1.28%Price chart
Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18
Key dataSep 18, 2026
OpenCNY 5.45
From 52W high−32.48%
Volume6.75M
Market capCNY 5.64B
P/E (TTM)30.1x
P/S (TTM)1.5x
Div yield1.03%
Key dataSep 18, 2026
Open
CNY 5.45
From 52W high
−32.48%
Volume
6.75M
Market cap
CNY 5.64B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
9.0x
P/E (TTM)
30.1x
RSI (14)
45.9
MomentumView details →
1D Return
+1.28%
YTD Return
−25.14%
Similar companies
Latest newsMore news →
Furida announced its 2026 half-year results: revenue of 1.909 billion yuan, up 6.69% year-on-year; net profit attributable to shareholders of 81.7815 million yuan, down 24.25% year-on-year; and no interim dividend or capital reserve conversion.26d agoSONG JIANBO increased his stake in Hengtong Co., Ltd. to 5% via block trading on July 17, 2026, and plans further purchases.65d ago